Gilles de la Tourette syndrome: Clinical spectrum and management;Síndrome de Gilles de la Tourette: Espectro clínico y tratamiento

Revista de Neurologia

Volumn 36, Issue 7, 2003, Pages 679-688

  Calderon Gonzalez R ^a,b   Calderon Sepulveda R F ^a  

^a Hospital San Jose Tec de Monterrey   (Mexico)

^b Ctro Neurologico Ninos/Adolescentes   (Mexico)

Author keywords

Attention deficit; Compulsions; Gilles de la Tourette syndrome; Hyperactivity; Learning disability; Obsessions; Tics

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIDEPRESSANT AGENT; BACLOFEN; BUSPIRONE; CALCIUM CHANNEL BLOCKING AGENT; CLOMIPRAMINE; CLONAZEPAM; CLONIDINE; DEXAMPHETAMINE; DOPAMINE; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; FLUOXETINE; FLUPHENAZINE; FLUVOXAMINE; GUANFACINE; HALOPERIDOL; LEVODOPA; NALTREXONE; NEUROLEPTIC AGENT; NIFEDIPINE; OLANZAPINE; PAROXETINE; PERGOLIDE; PIMOZIDE; RISPERIDONE; SERTRALINE; TETRABENAZINE; UNINDEXED DRUG; VERAPAMIL;

ATTENTION DEFICIT DISORDER; BASAL GANGLION; BEHAVIOR DISORDER; CARDIOTOXICITY; CLINICAL TRIAL; CORPUS STRIATUM; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DOPAMINERGIC SYSTEM; DRUG EFFECT; DRUG EFFICACY; FRONTAL CORTEX; GENETIC DISORDER; GILLES DE LA TOURETTE SYNDROME; HUMAN; LEARNING DISORDER; MULTIFACTORIAL INHERITANCE; NERVE TRACT; NEUROTRANSMISSION; OBSESSIVE COMPULSIVE DISORDER; PATHOGENESIS; PATHOPHYSIOLOGY; PATIENT EDUCATION; PROGNOSIS; REVIEW; SEDATION; SIDE EFFECT; TIC; BEHAVIOR THERAPY; COMORBIDITY; MENTAL DISEASE; METABOLISM;

BEHAVIOR THERAPY; COMORBIDITY; DIAGNOSIS, DIFFERENTIAL; DOPAMINE AGONISTS; HUMANS; MENTAL DISORDERS; PERGOLIDE; RECEPTORS, DOPAMINE; TICS; TOURETTE SYNDROME;

EID: 0037617980     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.3607.2002254     Document Type: Review

References (80)

1. Itard JMG. Mémoire sur quelques functions involontaires des appareils de la locomotion de la préhension et de la voix. Arch Gen Med 1825; 6: 385-407.
2. Gilles de la Tourette G. Étude sur une affection nerveuse caracterisée par de l'incoordination motrice accompagnée d'echolalie et de coprolalie. Arch Neurol 1885; 9: 19-42, 158-200.
3. Gilles de la Tourette G. La maladie des tics convulsifs. Sem Medicale 1899; 19: 153-6.
4. Stefl ME. Mental health associated with Tourette's syndrome. Am J Public Health 1984; 74: 1310-3.
5. Jankovic J, Stone L. Dystonic tics in patients with Tourette's syndrome. Mov Disord 1991; 6: 248-52.
6. Lang AE. Patient perception of tics and other movement disorders. Neurology 1991; 41: 223-8.
7. Shapiro AK, Shapiro ES, Young JG, Feinberg TE. Gilles de la Tourette syndrome. 2 ed. New York: Raven Press; 1988. p. 61-193.
8. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders. 4 ed. (DSM-IV). Washington, DC: American Psychiatric Association; 1994.
9. Kurlan R, Behr J, Medved I, Shoulson J, Pauls D, Kidd KK. Severity of Tourette's syndrome in one large kindred: implications for determination of disease prevalence rate. Arch Neurol 1987; 44: 268-9.
10. Calderón-González R, Calderón-Sepúlveda RF. Tourette syndrome. Current concepts. Int Pediatr 1993; 8: 176-88.
11. Riley D. Tourette syndrome. MedLink Neurology 1993-2002. San Diego CA: MedLink Corp.
12. Freeman RD, Fast DK, Burd L, Kerbeshian J, Robertson MM, Sandor P. An international perspective on Tourette syndrome: selected findings from 3,500 individuals in 22 countries. Dev Med Child Neurol 2000; 42: 436-47.
13. Pauls DL, Leckman JF. The inheritance of Gilles de la Tourette's syndrome and associated behaviors: evidence for autosomal dominant transmission. N Engl J Med 1986; 315: 993-7.
14. Mason A, Banerjee S, Eapen V, Zeitlin H, Robertson MM. The prevalence of Tourette syndrome in a mainstream school population. Dev Med Child Neurol 1998; 40: 292-6.
15. McMahon WM, Leppert M, Filloux F, van de Wetering BJM, Hasstedt S. Tourette symptoms in 161 related family members. Adv Neurol 1992; 58: 159-65.
16. Kurlan R, Whitmore D, Irvine C, McDermott MP, Como PG. Tourette's syndrome in a special education population: a pilot study involving a single school district. Neurology 1994; 44: 699-702.
17. Pauls DL. The genetics of Tourette syndrome. Curr Psychiatry Rep 2001; 3: 152-7.
18. Hyde TM, Stacey ME, Coppola R, Handel SF, Rickler KC, Weinberger DR. Cerebral morphometric abnormalities in Tourette's syndrome: a quantitative MRI study of monozygotic twins. Neurology 1995; 45: 1176-82.
19. Hanna PA, Janjua FN, Contant CF, Jankovic J. A study of bilinial transmission in syndrome families. Neurology 1999; 53: 813-8.
20. Lichter DG, Dmochowski J, Jackson LA, Trinidad KS. Influence of family history on clinical expression of Tourette's syndrome. Neurology; 52: 308-16.
21. Sadovnick D, Kurlan R. The increasingly complex genetics of Tourette's syndrome. Neurology 1997; 48: 801-2.
22. Comings DE, Comings BG. Tourette's syndrome and attention deficit disorder with hyperactivity: are they genetically related? J Am Acad Child Psychiatry 1984; 23: 138-46.
23. Pauls DL. Issues in genetic linkage of Tourette syndrome: phenotypic spectrum and genetic model parameters. Adv Intern Neurol 1992; 58: 151-7.
24. Singer HS, Butler IJ, Tune LE, Seifer WE, Coyle JT. Dopaminergic dysfunction in Tourette's syndrome. Ann Neurol 1982; 12: 361-6.
25. Klawans HL, Falk DK, Nausieda PA, Weiner WJ. Gilles de la Tourette's syndrome after long-term chlorpromazine therapy. Neurology 1978; 28: 1064-8.
26. Black KL, Mink JW. Response to levodopa challenge in Tourette's syndrome. Mov Disord [in press].
27. Gilbert DL, Sethuraman G, Sine L, Peters S, Sallee FR. Tourette's syndrome improvement with pergolide in a randomized, double-blind, crossover trial. Neurology 2000; 54: 1310-5.
28. Tourette's Syndrome Study Group. Treatment of ADHD in children with Tourette's syndrome (TACT Trial). Ann Neurol 2001 [in press].
29. Meyer P, Bohnen NI, Minoshima S. Striatal presynaptic monoaminergic vesicles are not increased in Tourette's syndrome. Neurology 1999; 53: 371-4.
30. 2 receptor imaging in Gilles de la Tourette syndrome. Acta Neurol Scand 2000; 101: 165-71.
31. Haber SN, Kowell NW, Vonsattel JP, Bird ED, Richardson EP. Gilles de la Tourette's syndrome: a posmortem neuropathological and immunohistochemical study. J Neurol Sci 1986; 75: 225-41.
32. Singer HS, Krowiak E, Nelson E, Moran T. Tourette's syndrome: a neurochemical analysis of postmortem cortical brain tissue. Ann Neurol 1990; 27: 443-6.
33. Peterson BS, Leckman JF, Scahill L, Naftolin F, Keefe D, Charest NJ, et al. Steroid hormones and CNS sexual dismorphisms modulate symptom expression in Tourette's syndrome. Psychoneuroendocrinology 1993; 17: 555-63.
34. Peterson BS, Riddle MA, Cohen DJ, Katz LD, Smith JC, Hardin MT, et al. Reduced basal ganglia volumes in Tourette's syndrome using threedimensional reconstruction techniques from magnetic resonance images. Neurology 1993; 43: 941-9.
35. Singer HS, Reiss AL, Brown JE, Aylward EH, Shih B, Chee E, et al. Volumetric MRI changes in basal ganglia of children with Tourette's syndrome. Neurology 1993; 43: 950-6.
36. Moriarty J, Varma AR, Stevens J, Fish M, Trimble MR, Robertson MM. A volumetric MRI study of Gilles de la Tourette's syndrome. Neurology 1997; 49: 410-5.
37. Alexander GE, Crutcher MD, DeLong MR. Basal ganglia thalamocortical circuits: parallel substrates for motor, oculomotor, 'prefrontal' and 'limbic' functions. Prog Brain Res 1990; 85: 119-46.
38. Peterson BS, Staib L, Scahill L, Zhang H, Anderson C, Leckman JF, et al. Regional brain and ventricular volumes in Tourette syndrome. Arch Gen Psychiatry 2001; 58: 427-40.
39. Stem E, Silbersweig DA, Chee KY, Holmes A, Robertson MM, Trimble M, et al. A functional neuroanatomy of tics in Tourette syndrome. Arch Gen Psychiatry 2000; 57: 741-8.
40. Fredericksen KA, Cutting LE, Hates WR, Mostofsky SH, Singer HS, Cooper KL, et al. Disproportionate increases of white matter in right frontal lobe in Tourette syndrome. Neurology 2002; 58: 85-9.
41. Zinner SH. Tourette disorder. Ped Rev 2000; 21: 372-82.
42. Erenberg G, Cruse RP, Rothner AD. The natural history of Tourette syndrome. A follow-up study. Ann Neurol 1987; 22: 383-5.
43. Bruun RD. The natural history of Tourette's syndrome. In Cohen DJ, Brunn RD, Leckman JF, eds. Tourette syndrome and tic disorders: clinical understanding and treatment. New York: J Wiley and Sons; 1988. p. 21-39.
44. Shapiro ES, Shapiro AK. Gilles de la Tourette syndrome and tic disorders. The Harvard Medical School Mental Health Letter 1989; 5.
45. Mostofsky S. Tourette syndrome: neurobehavioral aspects. MedLink Neurology 1993-2001; Arbor Publ Corp.
46. Holzer JC, Goodman WK, McDougle CJ, Baer L, Boyarsky BK, Leckman JF, et al. Obsessive-compulsive disorder with and without a chronic tic disorder. A comparison of symptoms in 70 patients. Br J Psychiatry 1994; 164: 469-73.
47. Como PG. Obsessive-compulsive disorder in Tourette's syndrome. Adv Neurol 1995; 67: 281-91.
48. Bierderman J, Faraone S, Spencer T, Wilens T, Norman D, Lapey KA, et al. Patterns of psychiatric comorbidity, cognition and psychosocial functioning in adults with attention deficit hyperactivity disorder. Am J Psychiatry 1993; 150: 1792-8.
49. Singer HS. Tourette syndrome. In Capute AJ, Accardo PJ, eds. Developmental disabilities in infancy and childhood. 2 ed. Vol. II. The spectrum of developmental disabilities. Baltimore: Brookes; 1996. p. 497-510.
50. Robertson MM, Trimble NR, Lees AJ. The psychopathology of the Gilles de la Tourette syndrome: a phenomenological study. Br J Psychiatry 1988; 152: 383-90.
51. Lombroso PJ, Scahill LD, Chappell PB, Pauls DL, Cohen DJ, Leckman JF. Tourette's syndrome: a multigenerational neuropsychiatric disorder. Adv Neurol 1995; 65: 305-18.
52. Walkup JT, Scahill LD, Riddle MA. Disruptive behavior, hyperactivity, and learning disabilities in children with Tourette's syndrome. Adv Neurol 1995; 65: 259-72.
53. Robertson MM, Yakeley JW. Obsessive-compulsive disorder and self-injurious behavior. In Kurland R, ed. Handbook of Tourette's Syndrome and related tic and behavioral disorders. New York: Marcel Dekker; 1993. p. 45-87.
54. Budman CL, Bruun RD, Park KS, Lesser M, Olson M. Explosive outbursts in children with Tourette's disorder. J Am Acad Child Adolesc Psychiatry 2000; 39: 1270-6.
55. Allen RP, Singer HS, Brown JE, Salam MM. Sleep disorders in Tourette syndrome: a primary or unrelated problem? Pediatr Neurol 1992; 8: 275-80.
56. Brookshire BL, Butler IJ, Ewing-Cobbs L, Fletcher JM. Neuropsychological characteristics of children with Tourette syndrome: evidence for a nonverbal learning disability? J Clin Exp Neuropsychol 1994; 16: 289-302.
57. Burd L, Kauffman DW, Kerbeshian J. Tourette syndrome and learning disabilities. J Learn Disabil 1992; 25: 598-604.
58. Schuerholtz LJ, Baumgardner TL, Singer HS, Reiss AL, Denkla MB. Neuropsychological status of children with Tourette's syndrome with and without attention deficit hyperactivity disorder. Neurology 1996; 46: 958-65.
59. De Groot CM, Yeates KO, Baker GB, Bornstein RA. Impaired neuropsychological functioning in Tourette's syndrome subjects with co-occurring obsessive-compulsive and attention deficit symptoms. J Neuropsychiatr Clin Neurosci 1997; 9: 267-72.
60. Castellanos FX. Stimulants and tic disorders. Arch Gen Psychiatry 1999; 56: 338-9.
61. Swedo SE, Leonard HL, Garvey M, Mittleman B, Allen AJ, Perlmuter S, et al. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases. Am J Psychiatry 1998; 155: 264-71.
62. Fahn S, Tics, myoclonus, and miscellaneous movement disorders. Cur Opin Neurol Neurosurg 1991; 4: 337-42.
63. Fahn S. Choreic disorders. Cur Opin Neurol Neurosurg 1989; 2: 319-23.
64. Markham CH. The dystonias. Cur Opin Neurol Neurosurg 1992; 5: 301-13.
65. Koller WC. Chorea, hemichorea, hemiballismus, choreoathetosis and related disorders of movement. Cur Opin Neurol Neurosurg 1991; 4: 350-3.
66. Lees AJ. Movement disorders in psychiatry. Cur Opin Neurol Neurosurg 1990; 3: 342-5.
67. Lang AE. Other hyperkinetic and paroxysmal movements. Cur Opin Neurol Neurosurg 1989; 2: 334-42.
68. Jankovic J. Diagnosis and classification of tics and Tourette syndrome. Adv Neurol 1992; 58: 7-14.
69. Buzan RD, Shore JH, O'Brien C, Schneck C. Obsessive-compulsive disorder and Tourette's Syndrome. Cur Treat Opin Neurol 2000; 2: 125-39.
70. Jiménez-Jiménez FJ, Garcia-Ruiz PJ. Pharmacological options for the treatment of Tourette's disorder. Drugs 2001; 61: 2207-20.
71. Kompoliti K, Goetz CG. Tourette syndrome. Clinical rating and quantitative assessment of tics. Neurol Clin 1997; 15: 239-54.
72. Singer HS, Wendlandt J, Kreiger M, Giuliano J. Baclofen treatment in Tourette syndrome. Neurology 2001; 56: 599-604.
73. Gilbert DL, Sethuraman G, Sine L, Peters S, Sallee FR. Tourette's syndrome improvement with pergolide in a randomized, double-blind, crossover trial. Neurology 2000; 54: 1310-5.
74. Marras C, Andrews D, Sime E, Lang AE. Botulinum toxin for simple motor tics. Neurology 2001; 56: 605-10.
75. Peterson AI, Azrin NH. An evaluation of behavioral treatments for Tourette syndrome. Behav Res Therapy 1992; 30: 167-74.
76. Babel TB, Wamke PC, Ostertag CB. Immediate and long term outcome after infrathalamic and thalamic lesioning for intractable Tourette's syndrome. J Neurol Neurosurg Psychiatry 2001; 70: 666-71.
77. Jenike MA. Neurosurgical treatment of obsessive-compulsive disorder. Br J Psychiatry Suppl 1998; 35: 78-90.
78. The Tourette's Syndrome Study Group. Treatment of ADHD in children with tics. Neurology 2002; 58: 527-36.
79. Feigin A, Kurlan R, McDermott M, Beach J, Dimitsopoulos T, Brower CA, et al. A controlled trial of deprenyl in children with Tourette's syndrome and attention deficit hyperactivity disorder. Neurology 1996; 45: 965-8.
80. Bruun RD, Budman CL. Paroxetine treatment of episodic rages associated with Tourette's syndrome. J Clin Psychiatry 1998; 59: 5814.